Bio-Rad Laboratories (BIO-B) Gross Profit (2009 - 2026)

Bio-Rad Laboratories (BIO-B) has 18 years of Gross Profit data on file, last reported at $309.4 million in Q1 2026.

• Quarterly Gross Profit rose 1.11% year-over-year to $309.4 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $1.3 billion (down 1.16% YoY) and the FY2025 annual result came in at $1.3 billion, down 2.83% from the prior year.
• Gross Profit slipped to $309.4 million in Q1 2026 per BIO-B's latest filing, from $345.2 million in the prior quarter.
• Across five years, Gross Profit topped out at $402.6 million in Q1 2022 and bottomed at $306.0 million in Q1 2025.
• The 5-year median for Gross Profit is $355.1 million (2024), against an average of $354.3 million.
• The widest annual swing landed in 2022, when Gross Profit dropped 14.64%; it then rose 6.02% in 2024.
• Tracing BIO-B's Gross Profit over 5 years: stood at $397.1 million in 2022, then slipped by 7.76% to $366.3 million in 2023, then declined by 6.63% to $342.0 million in 2024, then rose by 0.94% to $345.2 million in 2025, then declined by 10.37% to $309.4 million in 2026.
• Per Business Quant, the three latest BIO-B Gross Profit figures stand at $309.4 million (Q1 2026), $345.2 million (Q4 2025), and $343.4 million (Q3 2025).

Peer Comparison